Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.

Novo Nordisk is banking on its pen-filled device and insulin leadership in India to gain a strong market share despite ...

More than one in four UK adults are obese, but only a small number will be eligible for the latest treatment from the NHS ...

Danish pharma major Novo Nordisk launched Wegovy, its FDA-approved weekly weight-loss injection, in India on Tuesday. Priced ...

Danish pharma giant Novo Nordisk’s announcement comes months after launch of another top selling obesity drug Mounjaro in ...